Research programme: TRAIL receptor-based diagnostics - HGS

Drug Profile

Research programme: TRAIL receptor-based diagnostics - HGS

Alternative Names: TRAIL receptor-based diagnostics research programme - HGS

Latest Information Update: 12 Apr 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Human Genome Sciences
  • Class Diagnostic agents
  • Mechanism of Action Undefined mechanism
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes

Highest Development Phases

  • No development reported Cancer

Most Recent Events

  • 28 Jul 2010 diaDexus has been acquired by VaxGen
  • 26 Apr 2007 TRAIL receptor-based diagnostics are still in active development
  • 21 Oct 2003 Preclinical trials in Diagnostic tests in USA (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top